biostudies-literatureUnknown108Chen BShanghai Municipal Health Commission<h4>Background</h4>Jingyin granules (JY), one patented Chinese herbal formula, have been advised for treating coronavirus disease 2019 (COVID-19) in China. As of now, the safety and effectiveness of JY in treating COVID-19 patients were still to be evaluated.<h4>Purpose</h4>To investigate the safety and clinical effectiveness of JY in treating mild COVID-19 patients.<h4>Study design</h4>We carried out a prospective cohort study, as the highly infectious COVID-19 omicron variant ranged in Shanghai (ClinicalTrial.gov registration number: ChiCTR2200058692).<h4>Methods</h4>Participants infected with COVID-19, who were diagnosed as mild cases, were assigned to receive either JY (JY group) or traditional Chinese medicine placebo (placebo group) orally for 7 days. The primary clinical indicators Phytomedicine : international journal of phytotherapy and phytopharmacology154496https://www.ebi.ac.uk/biostudies/studies/S-EPMC9575312biostudies-literatureClinical efficacy of Jingyin granules, a Chinese patent medicine, in treating patients infected with coronavirus disease 2019.PMC9575312Shen JHuang WLyu HGao YZhang LFang MChen BYuan WYu XLi MXu YfalseClinical efficacy of Jingyin granules, a Chinese patent medicine, in treating patients infected with coronavirus disease 2019.<h4>Background</h4>Jingyin granules (JY), one patented Chinese herbal formula, have been advised for treating coronavirus disease 2019 (COVID-19) in China. As of now, the safety and effectiveness of JY in treating COVID-19 patients were still to be evaluated.<h4>Purpose</h4>To investigate the safety and clinical effectiveness of JY in treating mild COVID-19 patients.<h4>Study design</h4>We carried out a prospective cohort study, as the highly infectious COVID-19 omicron variant ranged in Shanghai (ClinicalTrial.gov registration number: ChiCTR2200058692).<h4>Methods</h4>Participants infected with COVID-19, who were diagnosed as mild cases, were assigned to receive either JY (JY group) or traditional Chinese medicine placebo (placebo group) orally for 7 days. The primary clinical indicators 2022-01-01T00:00:00Z2022 Oct2025-04-04T19:41:23.687Z2025-02-19T01:40:53.14ZS-EPMC95753123628865110.1016/j.phymed.2022.154496